Objective
Hormone-dependent cancers affect millions of people worldwide and are a great burden to society, both financially and in terms of healthcare resources. The steroid hormone progesterone plays critical roles in a variety of physiological functions as well as in the carcinogenesis of hormone-dependent cancers including breast and endometrial cancers. Progesterone regulates gene expression through histone modifications and chromatin remodeling. However, the role played by DNA methylation in this context has not been determined. DNA methylation (5-methylcytosine) generally represses gene transcription via methyl-binding proteins. Changes in DNA methylation levels are observed in carcinogenesis as well as in the dynamic regulation of genes which rapidly respond to stimuli. Ten-eleven translocation (TET) proteins hydroxylate the 5-methylcytosine during the demethylation process synthesizing 5-hydroxymethylcytosine (5hmC). 5hmC inhibits the interactions of methyl-binding proteins and can influence both long- and short-term regulation of gene transcription. The goal of this proposal is to identify DNA methylation and hydroxymethylation changes induced by progesterone in breast cancer cells. We will use hMeDIP-sequencing and combined glycosylation restriction analysis to measure the differential levels of 5-methylcytosine and 5-hydroxymethylcytosine marks. Furthermore, we propose to characterize the role of TET proteins in progesterone-mediated signaling. To this end, we plan to analyze gene expression and DNA methylation/hydroxymethylation changes in hormone-treated cells in the presence and absence of TET proteins. In addition, we will investigate TET binding in untreated and hormone-treated cells by ChIP assay. The outcome of this project will clarify the biological functions of 5-hydroxymethylcytosine in hormonal-mediated gene regulation and could lead to the identification of new targets for the diagnosis and treatment of hormone-dependent cancers.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences biological sciences genetics DNA
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences clinical medicine oncology breast cancer
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2011-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
08003 Barcelona
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.